Sabra Healthcare REIT Inc (SBRA) concluded trading on Thursday at a closing price of $16.68, with 3.36 million shares of worth about $55.98 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 2.56% during that period and on February 13, 2025 the price saw a gain of about 3.60%. Currently the company’s common shares owned by public are about 236.59M shares, out of which, 232.29M shares are available for trading.
Stock saw a price change of -0.66% in past 5 days and over the past one month there was a price change of -0.71%. Year-to-date (YTD), SBRA shares are showing a performance of -3.70% which increased to 23.54% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $13.17 but also hit the highest price of $19.99 during that period. The average intraday trading volume for Sabra Healthcare REIT Inc shares is 1.99 million. The stock is currently trading -0.59% below its 20-day simple moving average (SMA20), while that difference is down -2.50% for SMA50 and it goes to -0.38% lower than SMA200.
Sabra Healthcare REIT Inc (NASDAQ: SBRA) currently have 236.59M outstanding shares and institutions hold larger chunk of about 99.24% of that.
The stock has a current market capitalization of $3.95B and its 3Y-monthly beta is at 1.25. PE ratio of stock for trailing 12 months is 40.26, while it has posted earnings per share of $0.41 in the same period. Its PEG reads 0.30 while making debt-to-equity ratio of 0.91. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SBRA, volatility over the week remained 2.66% while standing at 2.46% over the month.
Stock’s fiscal year EPS is expected to rise by 741.67% while it is estimated to increase by 38.28% in next year. EPS is likely to grow at an annualized rate of 132.49% for next 5-years, compared to annual growth of -47.68% made by the stock over the past 5-years.
Coverage by JMP Securities stated Sabra Healthcare REIT Inc (SBRA) stock as a Mkt outperform in their note to investors on January 07, 2025, suggesting a price target of $20 for the stock. On December 05, 2024, Mizuho Downgrade their recommendations, while on October 01, 2024, Wells Fargo Upgrade their ratings for the stock with a price target of $20. Stock get a Buy rating from Citigroup on September 13, 2024.
